Table of Contents

company-logo

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Evolus Dividend Announcement

• Evolus does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Evolus dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Evolus Dividend Yield

Evolus current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Evolus stock? Use our calculator to estimate your expected dividend yield:

Evolus Financial Ratios

P/E ratio-13.87
PEG ratio0.14
P/B ratio130.59
ROE-966.29%
Payout ratio0.00%
Current ratio2.47
Quick ratio2.23
Cash Ratio1.40

Evolus Dividend FAQ

Does Evolus stock pay dividends?
Evolus does not currently pay dividends to its shareholders.
Has Evolus ever paid a dividend?
No, Evolus has no a history of paying dividends to its shareholders. Evolus is not known for its dividend payments.
Why doesn't Evolus pay dividends?
There are several potential reasons why Evolus would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Evolus ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Evolus has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Evolus a dividend aristocrat?
Evolus is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Evolus a dividend king?
Evolus is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Evolus a dividend stock?
No, Evolus is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Evolus stocks?
To buy Evolus you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Evolus stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.